Streamline Analysis of Clinical Trials Data
Start with the big picture, drill down to details
JMP Clinical software from SAS brings sophisticated analysis and exploration of clinical trials data to a dynamic safety review process. It combines the industry-leading power of SAS® Analytics with the graphical flexibility of JMP, the longstanding tool of choice in the clinical review community.
Medical reviewers, biostatisticians, data monitors and members of biometrics groups need to understand and report clinical trial data accurately and efficiently. JMP Clinical provides a collaborative environment that fosters exploration of medically relevant hypotheses with a statistical perspective.
A Venn diagram helps identify co-occurring adverse events for subjects in the study. Then you can select subjects for clustering or profiling.
JMP Clinical dynamically links advanced statistics with exceptional graphics to provide a detailed picture of clinical trial results. Its unsurpassed ease of use puts multifaceted analysis options in the hands of all users, regardless of their statistical savvy. Even reviewers without programming experience or statistical training can get started quickly, thanks to simplified dialogs and customized workflows.
A hallmark of JMP Clinical is its fluidity of movement between results for the entire trial and those for specific subjects via multifaceted drill-down and swim-up capabilities.
Ease migration to the modern review environment
JMP Clinical uses CDISC data, the globally recognized standard for clinical analysis and reporting. It organizes the review process, working behind the scenes to automate the analytics and reporting, allowing you more time to interpret and understand the results.
As one of the first tools that inherently understands ADaM data, JMP Clinical is a great option for clinicians and biostatisticians migrating into the modern review environment. Its optional 64-bit platform brings even more power to the analysis of vast data sets.
The software supports nine core CDISC domains for safety and efficacy review: demographics, adverse events, medical histories, disposition, exposure, concomitant medications, lab results, electrocardiograms and vital signs. With simple configuration, it can analyze results from other CDISC domains as well.
You can rely on JMP Clinical to:
Explore data visually and interactively, replacing static tables and listings.
Examine relationships between events, findings and interventions using dashboard visualizations of distributions and incidence screen analyses by demographic interactions.
Select specific time windows from almost any analysis.
Share reports easily, streamlining communications between internal reviewers, and then between sponsor organizations and regulatory agencies.
Fit advanced statistical models, including those with time windows.
See and explore data from every angle
A new Clinical Starter menu helps you load CDISC data and follow FDA reporting guidelines in logical sequence. A customizable, menu-driven desktop system lets you see and explore safety and efficacy data from every angle, and then easily share findings with others. You also can use dialogs to manipulate data on the fly and streamline interactions between collaborating groups.
JMP Clinical offers effortless access to the statistical analyses behind the graphics – a benefit not usually found in similar software tools. For example, JMP Clinical makes it easy to generate patient profiles by selecting individual subjects from any graph and to examine analysis results by groups – according to race, sex or other characteristics. Just summarize, elect, zoom in and drill down to the details.
JMP Clinical features industry-standard visualizations as well as novel graphics for displaying safety and efficacy data. Space-constrained views allow easy identification of differences between items in a graph in a single dashboard. A new mapping feature allows you to compare results across testing sites or countries.
